WITHUS PHARMACEUTICAL Co.,LTD.

₩6,540As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:330350Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (13.33%)
Div yield —
ROE 7.96%
Pharmaceutical Preparations
Beta (5Y) 0.69
PE TTM 10.84
TSR TTM 0.15%
Mkt cap ₩86.33B
ROIC 4.00%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,296
26.85%
159.01%
Sell 2|5|9|5|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
120.89
119.20
131.00
142.58
6.75%
0.18%
12.64%
25.73%
Revenue₩B
4.455
4.526
4.685
4.675
10.69%
14.05%
15.47%
10.75%
Peers (US$63.65M)
Cap (US$)
PE
60.85M
2.961x
Capital
TTM
5Y
10Y
Leveragex
1.051
0.035
0.029
EBIT/Intx
3.428
0.128
0.118
Own earn%
182.27
(8.02)
0.18
Sh yield%
38.19
20.71
20.83
Owners
Insiders/Inst%
11.56
47.99
Short interest%
1.40
SBC / revenue%
2.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
0–7
$1 testx
0.1
Incr. ROIC%
3